THURSDAY, Sept. 29, 2022 (HealthDay News) -- A new technology dubbed the "bionic pancreas" may beat standard treatment in helping people with type 1 diabetes control their blood sugar levels, a clinical trial has found.
A 3-D printed ear made with the patient's own cells has been transplanted onto a 20-year-old woman, the company that made the ear says.
The achievement announced June 2 by 3DBio Therapeutics of New York City is believed to be the first known example of a 3-D printed implant made of living tissues. Experts hailed it as a major advance in...
Physiotherapist David Putrino was working on a vibrating glove to help deaf people experience live music when a friend mentioned that the same technology might stop tremors in people with Parkinson's disease.
Putrino, director of rehabilitation innovation for Mount Sinai Health System in New York City, was intrigued. The friend's father had Parkinson's, so they placed the new device on hi...
The answer to helping kids with "lazy eye" before it's too late could be a hand-held screening device, a new study suggests.
Amblyopia can't be treated with glasses or contact lenses after a child's vision reaches maturity, and without treatment, it can lead to poor school performance and impairments in depth perception and fine motor skills, doctors say.
Digestive issues are common after spinal cord injury and can lead to chronic constipation and incontinence. But robotic exoskeleton-assisted walking can improve matters in people with such injuries, researchers say.
In an earlier survey, more than a third of men with spinal cord injury said bowel and bladder problems had the most significant effect on their lives after their injury.
An emerging technology could zap your post-op pain away -- little or no opioids needed.
The technique is called percutaneous peripheral nerve stimulation. It involves inserting a small wire next to a nerve and using a stimulator to deliver a mild electrical current to the affected area, interrupting pain transmission.
A team led by Dr. Brian Ilfeld, of the University of California, ...
TUESDAY, April 13, 2021 (HealthDay News) --The first device that uses artificial intelligence (AI) to help detect possible signs of colon cancer during colonoscopy has been approved by the U.S. Food and Drug Administration.
The GI Genius uses AI-based machine learning to help identify lesions such as polyps or suspected tumors in real time during a colonoscopy, according to the agency.
Dr. David Wheeler started seeing patients via telehealth in his Wyoming neurology practice 10 years ago as a way to provide routine visits to patients living in remote areas. He'd see three to four patients by video or telephone chat each day, which only made up about a fifth of his regular practice.
Then the new coronavirus began to spread across the nation. Now, even though Wyoming...
An international team has designed a computer program that predicts with up to 80% accuracy which COVID-19 patients will develop serious respiratory disease.
Developed by U.S. and Chinese researchers, the artificial intelligence (AI) program has been tested at two hospitals in China with 53 patients who were diagnosed in January with COVID-19. The new tool is considered experiment...
Smartphones appear to be more effective than wearable fitness devices in helping doctors track patients' physical activity, researchers say.
Their new study included 500 patients who joined activity tracking programs at two Philadelphia hospitals. Half used a smartphone app to track their daily steps after leaving the hospital. The other half used a wearable device.
It was a race with life-or-death implications: Unmanned drones were pitted against traditional emergency responders to see which could get an automated external defibrillator to the rural site of a simulated cardiac arrest first.
The drones won handily. And the Canadian researcher behind the test said such a system might be ready for the real world in as little as a year.
Blood vessels created in the lab can successfully turn into "living tissue" in patients on dialysis for advanced kidney disease, a new study suggests.
The results come from just 13 patients in an early-phase trial. But researchers said they are a sign that the engineered tissue might eventually offer new treatment options for patients with damaged blood vessels -- due to conditions rang...